Company · LV
PrintyMed
Developing materials for medical applications such as organ-on-a-chip and wound dressings.
- Raised
- —
- Last round
- —
- Momentum
- Quiet
- Events
- 3
- Last activity
- 14 Oct 2026
Updated 12 Sep 2026 · Reviewed 12 Sep 2026
Activity
3 events
- Launch14 Oct 2026
PrintyMed is developing biomaterials for medicine from spider silk, aiming to create artificially generated organs.
▸Source: pmo.ee
“Jekaterinai Romanovai ļoti patīk suņi. Vēl viņa ir sieviete ar lielu misiju, un tieši tas viņai palīdzējis virzīties cauri dzīvei. Rezultātā – iekļauta Forbes Latvia "30 under 30" un dibinājusi trīs…”
- Launch07 Aug 2026
PrintyMed is developing a material for various medical applications, aiming to bring innovative solutions to the market.
▸Source: pmo.ee
“Latvijas jaunuzņēmums “PrintyMed” attīsta materiālu, no kura nākotnē varētu izgatavot membrānas orgāniem uz čipa, brūču pārsējus, sirds vārstuļus un pat mākslīgo orgānu ietvarus. Ceļš no…”
- Launch01 Jan 2023
PrintyMed is launching a new artificial spider silk material for various medical applications, including organ-on-a-chip and wound dressings.
▸Source: Labs of Latvia
“Latvijas jaunuzņēmums “PrintyMed” attīsta materiālu, no kura nākotnē varētu izgatavot membrānas orgāniem uz čipa, brūču pārsējus, sirds vārstuļus un pat mākslīgo orgānu ietvarus.”
People
5 people
Gints Šmits
Jekaterina Romanova
CEO and co-founder
Kristaps Jaudzems
Sandra Treide
Medical Technology Expert
Viktors Romaņuks
Questions
3 answers
- What does PrintyMed do?
- Developing materials for medical applications such as organ-on-a-chip and wound dressings.
- When was PrintyMed founded?
- PrintyMed was founded in 2023.
- Where is PrintyMed headquartered?
- PrintyMed is based in Latvia.
The newsletter
One issue a week. Tuesday at 06:00 CET.
Funding rounds, exits, hires, and launches from eight Nordic and Baltic countries. Read in under five minutes, with one editor’s judgement on every issue.
No ads · No algorithmic feed · Free